Cargando…
One-carbon metabolism: An aging-cancer crossroad for the gerosuppressant metformin
The gerosuppressant metformin operates as an efficient inhibitor of the mTOR/S6K1 gerogenic pathway due to its ability to ultimately activate the energy-sensor AMPK. If an aging-related decline in the AMPK sensitivity to cellular stress is a crucial event for mTOR-driven aging and aging-related dise...
Autores principales: | Menendez, Javier A., Joven, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708048/ https://www.ncbi.nlm.nih.gov/pubmed/23525940 |
Ejemplares similares
-
Gerosuppressant Metformin: less is more
por: Menendez, Javier A., et al.
Publicado: (2011) -
Gerosuppression in confluent cells
por: Leontieva, Olga V., et al.
Publicado: (2014) -
Metformin and cancer: Quo vadis et cui bono?
por: Menendez, Javier A., et al.
Publicado: (2016) -
Tumor suppression by p53 without apoptosis and senescence: conundrum or rapalog-like gerosuppression?
por: Blagosklonny, Mikhail V.
Publicado: (2012) -
Nutrients in Energy and One-Carbon Metabolism: Learning from Metformin Users
por: Luciano-Mateo, Fedra, et al.
Publicado: (2017)